1. Introduction {#sec0005}
===============

Epidemiological studies suggest that during sensitive periods of fetal development, prenatal environmental events, including exposure to maternal psychological distress (PD), are important factors for shaping the risk for morbidity later in life ([@bib0060]; www.dohad.org). More specifically, recent evidence demonstrates an association between prenatal maternal PD exposure and the later development of immune-related disorders, such as recurrent respiratory infections ([@bib0040]) or asthma and atopic disorders ([@bib0010]).

Prenatal exposure to maternal PD may affect the development of the fetus/infant hypothalamic-pituitary-adrenal (HPA) axis ([@bib0060]). Lymphoid organs, and particularly the thymus, display a markedly elevated expression of glucocorticoid receptors during extra-uterine life ([@bib0055]). In transgenic mice with impaired glucocorticoid function, the important role of glucocorticoids in the ontogeny of the immune system has been demonstrated ([@bib0065]). In contrast to the traditional view of glucocorticoids as immunosuppressant hormones, they are more accurately conceptualized as immunomodulatory hormones that can both stimulate as well as suppress immune function ([@bib0050]). If the communication between the HPA axis and immune system is disrupted, for example by prenatal maternal PD, then important alterations in anti-viral immune responses may take place ([@bib0015]; [@bib0075]). Bi-directional communication between the neuroendocrine and immune systems plays a significant regulatory role in response to a viral infection ([@bib0015]). For example, in the general infant population, rhinovirus infections are common, often asymptomatic and do not cause long-term viral persistence in the respiratory tract, while in vulnerable subjects rhinovirus infection-induced wheezing during early life might be a marker for a susceptibility for the later development of asthma ([@bib0030]; [@bib0045]).

In humans, the relationship between the exposure to maternal prenatal PD, the HPA axis functioning and anti-viral immune responses during early infancy have not been studied, so far. Here, we aimed at bridging and integrating previous data and to investigate whether maternal prenatal PD is associated with the early infant HPA axis reactivity, and whether this association is different in the presence of subclinical rhinovirus infection. We hypothesized that infant HPA axis reactivity is altered after exposure to prenatal PD, and the altered functioning related to this exposure emerges or is especially evident during a concurrent subclinical rhinovirus infection, which can be considered a natural stressor challenging the HPA axis functioning with relevance to the offspring's later health

2. Methodology {#sec0010}
==============

2.1. Definition of maternal psychological distress during pregnancy {#sec0015}
-------------------------------------------------------------------

The FinnBrain Birth Cohort Study investigates the effects of prenatal and early-life stress exposure on child health ([@bib0035]). Within the main Cohort, a nested case-control study, called the Focus Cohort, was established to enable comparisons between subjects exposed to different types of prenatal PD with their non-exposed controls (Supplementary Material). To define maternal PD, the questionnaires for symptoms of depression (Edinburgh Postnatal Depression Scale \[EPDS\]), overall anxiety (Symptom Checklist-90, anxiety scale \[SCL-90\]) and pregnancy-related anxiety symptoms (Pregnancy-Related Anxiety Questionnaire-Revised 2 \[PRAQ-R2\]) were used at gwks 14, 24, and 34. Exploratory analyses establishing cut-points for the approximate highest and lowest 25^th^ percentiles of maternal PD during pregnancy were performed. The total sum score cut-off points for the PD exposure and non-exposure were as follows: ≥12 and ≤ 6 for the EPDS, ≥10 and ≤ 4 for the SCL-90 anxiety subscale, and ≥ 34 and ≤ 25 points for PRAQ-R ([@bib0035]). The criteria to become identified as a case were: 1) scoring at least once above the selected threshold on two different questionnaires, 2) scoring at least twice above the selected threshold on the same instrument at any of the three prenatal time points, or 3) prenatal maternal use of serotonin reuptake inhibitors (SSRIs). The non-exposed controls needed to remain below the thresholds in all assessments ([@bib0035]).

2.2. Study design and population {#sec0020}
--------------------------------

The outcome of the current study was the infant HPA axis reactivity in response to an acute stressor in 10-week-old infants from the Focus Cohort (Flow chart, Fig. A.1). Due to project logistics (i.e., availability of assisting personnel) and factors not systematically related to any family characteristics, 792 families from the Focus Cohort target population (n = 1219) were attempted to be reached by phone for recruiting the infants for the current study. Out of those families who were reached (n = 586), a total of 418 (71%) agreed to participate in the study, and 168 (21%) declined. Eventually 374 infants attended the stress test, 38 infants were excluded from the data analyses (Fig.A.1). Thus, the final analyses of the current study comprised of 336 infants with adequate cortisol and virus samples. Data on maternal characteristics were collected from the self-report questionnaires at gestational weeks (gwks) 14, 24, and 34, while infant characteristics were obtained from the patient charts and Medical Birth Register of National Institute for Health and Welfare ([www.thl.fi](http://www.thl.fi){#intr0005}) ([@bib0035]). The study was approved by the Ethics Committee of the Hospital District of Southwest Finland and commenced only after obtaining written informed consent from the guardians.

2.3. The stress test of infant HPA axis reactivity {#sec0025}
--------------------------------------------------

The stress test was carried out to investigate the outcome of infant HPA axis reactivity. The study visits were performed on October 2012 to February 2016 at 8:30 a.m.-6:00 p.m. in the research facilities. The study visit started with a peaceful period in order to standardize the baseline cortisol sampling. The stressor included a standardized pediatric examination with venipuncture and a nasal swabbing of each a source of mild physical discomfort. The infant HPA axis reactivity to the stressor was assessed measuring five saliva cortisol samples at: baseline, 0, 15, 25 and 35 min after a stressor. The saliva cortisol samples were collected using Salimetrics infant swabs (Stratech, Suffolk, UK) by a research nurse or a researcher. The polymer swab was held in an infant's mouth for two minutes. Saliva was collected by centrifuging tubes (15 min, 1800 x g, 4 °C) and immediately frozen at −70 °C. The research nurse filled the protocol record form to keep track of timing, infant feeding, and possible deviations from the study protocol. The cortisol concentrations were measured with Cortisol Saliva Luminescence Immunoassay (IBL International, Hamburg, Germany).

2.4. Virus testing {#sec0030}
------------------

The nasal swab specimen for virus assessment was taken from front nostril and stored at −80 °C before the analysis. Swabs were suspended in phosphate-buffered saline, and nucleic acids were extracted by NucliSense easyMag (BioMerieux, Boxtel, the Netherlands) or a MagnaPure 96 (Roche, Penzberg, Germany) automated extractor. PCR for adenovirus, bocavirus, coronaviruses, enteroviruses, metapneumovirus, influenza A and B viruses, respiratory syncytial virus A and B, rhinovirus, and parainfluenza virus types 1--4 was performed using a commercial multiplex test kit (Anyplex^™^RV16, Seegene, Seoul, Korea). The participating infants were without signs or symptoms of acute febrile respiratory infection as determined and systematically documented by a pediatrician during the study visit.

2.5. Statistical analyses {#sec0035}
-------------------------

As the measure for the HPA axis reactivity, the area under the curve above/below the baseline (AUC~i~) was used (Fig. A.2.). Log-transformed (natural logarithm) cortisol values were used in the calculations to avoid outlying AUC~i~ values. Only the infants with a baseline cortisol value and ≥2 measured/available cortisol values after the acute stressor were included in the analyses (Fig. A.1). The missing cortisol values for the infants included in the analyses were imputed using multiple imputation. The analyses of how AUC~i~ associated with the PD exposure (PD *vs.* control), rhinovirus status (+ *vs.* -), and infant sex assessments were done using the t-tests. The main hypothesis being that the HPA axis reactivity is altered in the PD/rhinovirus + group was tested with an appropriate linear regression model, where infant sex was also controlled. Covariates for the adjusted model were selected based on statistical and clinical relevance (Table 1; Supplementary Material). Sensitivity analyses, excluding the mothers using SSRIs or corticosteroids, were performed to estimate the potential confounding effect of maternal medication. As the exclusion of these two groups did not alter the results, they were retained in the final analyses to maintain population representativity (Supplementary Material). All statistical analyses were performed in R 3.5.1 (R Core Team 2018).

3. Results {#sec0040}
==========

The study population included 336 10-week-old infants of whom 177 (53%) were boys, 148 (44%) were exposed to PD, and 76 (23%) were rhinovirus-positive ([Table 1](#tbl0005){ref-type="table"} ). Other viruses than the rhinovirus presented with only single positive findings in this general population-based study. No differences were found in the selected background characteristics between the PD (n = 148) and control (n = 188) groups with the exceptions of lower maternal education level (*p* = .004) and smoking during pregnancy (*p* \< .001) associating with PD ([Table 1](#tbl0005){ref-type="table"}).Table 1Study characteristics.Table 1PD exposed (n = 148)Controls (n = 188)*p*Infant characteristics at birthGestational age, weeks (SD)39.4 (1.4)40.0 (1.6).30Birth weight, g (SD) / length, cm (SD)3595 (440)/ 51 (2)3581 (487) / 51 (2).69/.89Head circumference, cm (SD)35 (1.3)35 (1.5).90Umbilical artery, pH (SD)7.27 (0.8)7.28 (0.8).13Male sex, nr (%)80 (54)97 (52).65[Maternal characteristics during pregnancy]{.ul}Maternal age at birth, years (SD)30 (4.5)31 (4.3)*.05*Maternal pre-pregnancy body-mass index,\
kg/m^2^ (SD)25.1 (5.1)24 (4.0).11Maternal education, nr (%)\
low (up to 12 years)\
middle (13-15 years)\
high (over 15 years)63 (44)\
36 (24)\
47 (32)48 (25)\
56 (30)\
84 (45)*.004*Maternal smoking, nr (%)24 (16)6 (3)*\<.001*Maternal use of inhaled or oral corticosteroids, nr (%)3 (2)7 (4).37Rhinovirus-positive infants at stress test, nr (%)31(21)45 (24).50Infant age at stress test, weeks (SD)10.8 (2.0)10.6 (2.0).21[^1]

The infant HPA axis reactivity was not independently associated with the PD exposure (*p* =  .30) or rhinovirus status (*p* =  .09), but girls had higher AUC~i~ than boys (*p* =  .003) (Fig. A.3). Our hypothesis of HPA axis activity being different in the group of the composite phenotype of PD/rhinovirus+ was tested by comparing the PD/rhinovirus+ group with the average of control/rhinovirus+, PD/rhinovirus- and control/rhinovirus- groups, while controlling for infant sex. The AUC~i~ was lower in PD/rhinovirus + than in the other groups (difference: 14.7 ln \[nmol/L\] × min; 95% confidence interval \[CI\] 3.8--25.6; *p* =  .008) ([Fig. 1](#fig0005){ref-type="fig"} a-b). The same comparison was separately tested for boys and girls, and the AUC~i~ difference was significant in boys (*p* =  .04) but not in girls (*p* =  .09) ([Fig. 1](#fig0005){ref-type="fig"}c). Controlling for maternal education level and smoking did not alter results (15.3 ln \[nmol/L\] × min; 95% CI 4.1--26.4; *p* =  .007). Finally, we tested the effect of the rhinovirus status within the PD group. The AUC~i~ was lower in PD/rhinovirus + than in PD/rhinovirus- group (difference: 14.9 ln \[nmol/L\] × min; 95% CI 3.3--27.3; *p* = .01).Fig. 1During the stress test: a) AUC~i~ was compared between the PD/rhinovirus + group and the average of control/rhinovirus+, PD/rhinovirus-, and control/rhinovirus- groups; b) mean cortisol values at five time points: baseline, 0 min, 15 min, 25 min and 35 min after stressor; and c) AUC~i~ was compared between the groups separately in girls and boys. The standard boxplots demonstrate the AUC~i~ in the groups.*AUC~i~:* area under the curve above/below baseline, *PD:* exposure to prenatal psychological distress.Fig. 1

4. Discussion {#sec0045}
=============

This is the first human-based study to investigate associations between prenatal PD exposure and early infant HPA axis reactivity, when a concurrent rhinovirus infection that challenged the immune system was present. Interestingly, we found that after the preceding prenatal PD exposure, the rhinovirus-positive infants had a blunted cortisol response in a stress test in comparison with their non-PD-exposed- and only PD-exposed counterparts. This association was more clearly seen in boys than in girls. Sex differences in HPA axis functioning have been reported previously ([@bib0020]; [@bib0025]). While human-based studies with a design similar to ours are lacking, so far, our results are in line with a mouse model study reporting that stress-exposed male mice had a blunted corticosterone response to influenza A virus compared to females ([@bib0005]).

Viral-induced inflammation activates the systemic stress response. Secreted glucocorticoids, the end-effectors of the HPA axis, protect peripheral organs from inflammation-induced tissue damage by suppressing an overshoot of the host immune reaction. In our study, the infants with prenatal PD exposure had suppressed HPA axis reactivity during rhinovirus infection. The consensus is that rhinovirus does not cause asthma in a straight-forward manner but rather brings up a child\'s underlying vulnerability trait of an altered immune response ([@bib0045]). The origins of these immunological alterations are not well understood, and PD exposure could be among the related factors.

The strengths of this study are the prospective design, relatively large sample size without major exclusion criteria and representing non-clinical populations, comprehensive data on maternal PD, a novel focus on the infant HPA axis reactivity during subclinical virus infection, a standardized baseline cortisol sampling and physical stressor, and good quality of the cortisol and virus measurements. As a limitation, some analyses of interest were precluded by the low number of infants in subpopulations due to the challenges in recruitment. Further, the inflammatory response to the infectious challenge was not measured. Regarding the generalizability of the results, it is noteworthy that the relation between prenatal PD and HPA axis responses may depend on infant age, sex, and/or the nature of the stressor ([@bib0025]; [@bib0070]).

4.1. Conclusions {#sec0050}
----------------

Our finding of the PD/rhinovirus + group having blunted cortisol secretion in comparison with control/rhinovirus+, PD/rhinovirus-, and control/rhinovirus- groups gives rise to a hypothesis that maternal prenatal PD during pregnancy is related to the early programming and development and interrelations of infant HPA axis and immune system placing our results in the context of fetal programming. Studies are needed to test whether the observed suppression of HPA axis in the context of rhinovirus infection associates with later disease development, such as atopic disorders and wheezing or asthma ([@bib0045]), and to further investigate child sex in its vulnerability to PD exposure.
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[^1]: p values are based on χ² and Mann-Whitney U tests for categorical and continuous variables, respectively. Bold values signify significance. *PD*: prenatal psychological stress, *SD*: standard deviation.
